Cargando…
Hemodialysis and erythrocyte epoxy fatty acids
Fatty acid products derived from cytochromes P450 (CYP) monooxygenase and lipoxygenase (LOX)/CYP ω/(ω‐1)‐hydroxylase pathways are a superclass of lipid mediators with potent bioactivities. Whether or not the chronic kidney disease (CKD) and hemodialysis treatments performed on end‐stage renal diseas...
Autores principales: | Gollasch, Benjamin, Wu, Guanlin, Liu, Tong, Dogan, Inci, Rothe, Michael, Gollasch, Maik, Luft, Friedrich C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592498/ https://www.ncbi.nlm.nih.gov/pubmed/33112511 http://dx.doi.org/10.14814/phy2.14601 |
Ejemplares similares
-
Maximal exercise and erythrocyte epoxy fatty acids: a lipidomics study
por: Gollasch, Benjamin, et al.
Publicado: (2019) -
Effects of hemodialysis on blood fatty acids
por: Gollasch, Benjamin, et al.
Publicado: (2020) -
Maximal exercise and erythrocyte fatty‐acid status: a lipidomics study
por: Gollasch, Benjamin, et al.
Publicado: (2019) -
Effects of hemodialysis on plasma oxylipins
por: Gollasch, Benjamin, et al.
Publicado: (2020) -
Bioaccumulation of Blood Long-Chain Fatty Acids during Hemodialysis
por: Liu, Tong, et al.
Publicado: (2022)